|
|
Severe Hypertension with Hypokalemia and Nephroangiosclerosis Due to Liddle Syndrome’s Mutation
|
Abstract:
Background: Liddle syndrome (LS) is a rare autosomal-dominant cause of early-life hypertension. It is associated with hypokalemic metabolic alkalosis, hyporeninemia, and suppressed aldosterone secretion. Its morbidity and mortality are associated with hypertension and hypokalemia. The Case: An 18-year-old man with severe hypertension, hypokalemia and renal failure for years. He was treated with multiple antihypertensive drugs yet without adequate control. In this patient; LS was confirmed by biochemical and hormonal profiles as well as genetic testing. His close family-members were clinically normal and by genetic testing indicating a new mutation in our patient. He was subjected to kidney biopsy since he had; high serum creatinine at 140 umol/L and bilateral small kidneys at 9 cm, in longitudinal diameter, with thin and echogenic cortex. It showed moderate nephroangiosclerosis. Initially, he was treated with low-salt diet, Amiloride 20 mg daily, slow K and antihypertensives (Amlodipine 10 mg daily and alpha methyl dopa 250 mg twice daily). Subsequently, antihypertensives were reduced to only Amlodipine 5 mg daily. He remained stabilized her disease up to 2 years of follow-up. Conclusion: LS should be considered in hypertensive children with hypokalemia since it requires special management to avoid its hypokalemic and cardiovascular complications as well as nephroangiosclerosis.
| [1] | Zhang, J. (2023) Hereditary Causes of Hypertension Due to Increased Sodium Transport. Current Opinion in Pediatrics, 36, 211-218. https://doi.org/10.1097/mop.0000000000001304 |
| [2] | Hanukoglu, I. and Hanukoglu, A. (2016) Epithelial Sodium Channel (ENaC) Family: Phylogeny, Structure-Function, Tissue Distribution, and Associated Inherited Dis-eases. Gene, 579, 95-132. https://doi.org/10.1016/j.gene.2015.12.061 |
| [3] | (2020) European Rare Kidney Diseases Reference Network, Update May 2020. |
| [4] | Wang, L., Yang, K., Jiang, X., Wu, H., Zhang, H., Zou, Y., et al. (2015) Prevalence of Liddle Syndrome among Young Hypertension Patients of Undetermined Cause in a Chinese Population. The Journal of Clinical Hypertension, 17, 902-907. https://doi.org/10.1111/jch.12598 |
| [5] | Rapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Shah, A.D., Denaxas, S., et al. (2014) Blood Pressure and Incidence of Twelve Cardiovascular Diseases: Lifetime Risks, Healthy Life-Years Lost, and Age-Specific Associations in 1·25 Million People. The Lancet, 383, 1899-1911. https://doi.org/10.1016/s0140-6736(14)60685-1 |
| [6] | Tse, G., Li, K.H.C., Cheung, C.K.Y., Letsas, K.P., Bhardwaj, A., Sawant, A.C., et al. (2021) Arrhythmogenic Mechanisms in Hypokalaemia: Insights from Pre-Clinical Models. Frontiers in Cardiovascular Medicine, 8, Article 620539. https://doi.org/10.3389/fcvm.2021.620539 |
| [7] | Kamel, K.S., Ethier, J.H., Richardson, R.M.A., Bear, R.A. and Halperin, M.L. (1990) Urine Electrolytes and Osmolality: When and How to Use Them. American Journal of Nephrology, 10, 89-102. https://doi.org/10.1159/000168062 |
| [8] | Lin, S., Yang, S. and Chau, T. (2010) A Practical Approach to Genetic Hypokalemia. Electrolytes & Blood Pressure, 8, 38-50. https://doi.org/10.5049/ebp.2010.8.1.38 |
| [9] | Walker, B.R., Campbell, J.C., Fraser, R., Stewart, P.M. and Edwards, C.R.W. (1992) Mineralocorticoid Excess and Inhibition of 11 Β‐hydroxysteroid Dehydrogenase in Patients with Ectopic ACTH Syndrome. Clinical Endocrinology, 37, 483-492. https://doi.org/10.1111/j.1365-2265.1992.tb01478.x |
| [10] | Palermo, M., Delitala, G., Mantero, F., Stewart, P.M. and Shackleton, C.H.L. (2001) Congenital Deficiency of 11 β-Hydroxysteroid Dehydrogenase (Apparent Mineralocorticoid Excess Syndrome): Diagnostic Value of Urinary Free Cortisol and Cortisone. Journal of Endocrinological Investigation, 24, 17-23. https://doi.org/10.1007/bf03343803 |
| [11] | Chrousos, G. (2011) Q&A: Primary Generalized Glucocorticoid Resistance. BMC Medicine, 9, Article No. 27. https://doi.org/10.1186/1741-7015-9-27 |
| [12] | White, P.C., New, M.I. and Dupont, B. (1987) Congenital Adrenal Hyperplasia. New England Journal of Medicine, 316, 1580-1586. https://doi.org/10.1056/nejm198706183162506 |
| [13] | Pacak, K. and Eisenhofer, G. (2007) An Assessment of Biochemical Tests for the Diagnosis of Pheochromocytoma. Nature Clinical Practice Endocrinology & Metabolism, 3, 744-745. https://doi.org/10.1038/ncpendmet0615 |
| [14] | Geller, D.S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A., et al. (2000) Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by Pregnancy. Science, 289, 119-123. https://doi.org/10.1126/science.289.5476.119 |
| [15] | Liddle, G.W., Bledose, T. and Coppage Jr., W.S. (1963) A Familial Renal Disorder Simulating Primary Aldosteronism with Negligible Aldosterone Secretion. Transactions of the Association of American Physicians, 76, 199-213. |
| [16] | Nakada, T., Koike, H., Akiya, T., Katayama, T., Kawamata, S., Takaya, K., et al. (1987) Liddle’s Syndrome, an Uncommon Form of Hyporeninemic Hypoaldosteronism: Functional and Histopathological Studies. Journal of Urology, 137, 636-640. https://doi.org/10.1016/s0022-5347(17)44161-9 |
| [17] | Unwin, R.J., Luft, F.C. and Shirley, D.G. (2011) Pathophysiology and Management of Hypokalemia: A Clinical Perspective. Nature Reviews Nephrology, 7, 75-84. https://doi.org/10.1038/nrneph.2010.175 |
| [18] | Monticone, S., Buffolo, F., Tetti, M., Veglio, F., Pasini, B. and Mulatero, P. (2018) Genetics in Endocrinology: The Expanding Genetic Horizon of Primary Aldosteronism. European Journal of Endocrinology, 178, R101-R111. https://doi.org/10.1530/eje-17-0946 |
| [19] | Büyükkaragöz, B., Yilmaz, A.C., Karcaaltincaba, D., Ozdemir, O. and Ludwig, M. (2016) Liddle Syndrome in a Turkish Family with Heterogeneous Phenotypes. Pediatrics International, 58, 801-804. https://doi.org/10.1111/ped.12985 |
